# Teicoplanin Allergy Testing Using Autologous Serum (TATAS)

> **NCT06803758** · NA · RECRUITING · sponsor: **University Hospital Southampton NHS Foundation Trust** · enrollment: 20 (estimated)

## Conditions studied

- Drug Allergy

## Interventions

- **DIAGNOSTIC_TEST:** Teicoplanin Allergy Testing using autologous serum

## Key facts

- **NCT ID:** NCT06803758
- **Lead sponsor:** University Hospital Southampton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-08
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06803758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06803758, "Teicoplanin Allergy Testing Using Autologous Serum (TATAS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06803758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*